Proceedings of the National Academy of Sciences of the United States of AmericaOct 30, 2025

New Discoveries on How Tick-Borne Encephalitis Viruses Enter Cells

Updated Jan 2, 2026

Abstract

LRP8 is identified as a candidate receptor for tick-borne encephalitis viruses (TBEV), facilitating their entry into cells.

Tick-borne encephalitis viruses cause significant neurological disease in humans.
Members of the low-density lipoprotein receptor family may serve as receptors for certain viruses.
LRP8 was found to facilitate TBEV infection in neuronal cells through specific interactions with virus envelope proteins.
Genetic removal of LRP8 impaired TBEV infection, while its expression enhanced viral entry.
Soluble LRP8 decoy receptors were effective in neutralizing TBEV in cell cultures.
Knockout mice lacking LRP8 showed reduced viral infection in neuronal cells.

Simplified

Orthoflaviviruses are a genus of arthropod-transmitted RNA viruses that infect humans and other vertebrate animals on a global scale, resulting in extensive morbidity and mortality. Among the orthoflaviviruses, tick-borne encephalitis viruses (TBEV) are an antigenic group that causes severe neurological disease in humans. However, the entry receptors for TBEV, which contribute to cell and tissue tropism, remain largely unknown. Because recent studies identified members of the low-density lipoprotein receptor (LDLR) family as possible receptors for some orthoflaviviruses and distantly related alphaviruses, we performed a targeted screen in transgenic cells expressing different LDLR members and identified LRP8 (also called ApoER2) as a candidate receptor for TBEV strains from the five different subtypes. Genetic ablation ofimpaired TBEV reporter virus particle or authentic virus infection in neuronal cells. Reciprocally, complementation or ectopic expression ofincreased TBEV infection. LRP8 was used as a receptor by multiple strains of TBEV and several closely related tick-borne viruses but not by the mosquito-transmitted orthoflaviviruses we tested. LRP8 bound directly to TBEV envelope proteins and promoted virus attachment to and internalization in cells through LDLR type A (LA) binding domain, which we narrowed down to LA domains 1 and 2 through functional experiments. Soluble LRP8-Fc decoy receptors neutralized TBEV in cell culture, and reduced viral infection was observed inneuronal cells obtained from knockout mice. Our studies establish a role for LRP8 in TBEV entry and infection, which has implications for the development of soluble receptor, antibody-based, and vaccine countermeasures. LRP8LRP8Lrp8 -/-

Funding

Competing interests

Competing interests statement:M.S.D. is a consultant or on a Scientific Advisory Board for Inbios, IntegerBio, Akagera Medicines, GlaxoSmithKline, Merck, and Moderna. D.H.F. and J.W.S. coauthored a Keystone Symposia report in 2023.

PubMed

Abstract

Funding

Competing interests

What Lands in Your Inbox Each Week: